Moderna and Merck’s Personalized mRNA Melanoma Vaccine: What the Numbers Really Show
A personalized cancer Melanoma vaccine developed by Moderna and Merck has produced positive results in a large Phase 3 clinical […]
Latest Breakthrough
AI-Designed Viruses: How Artificial Intelligence Created New Bacteriophages and What It Means for Medicine
Artificial intelligence has taken another major step into biology. Scientists have used genome-focused AI models to design new bacteriophages that function in laboratory experiments, raising hopes for future phage therapies against resistant bacteria while also prompting important questions about biosafety and biosecurity. Learn how AI-designed viruses could affect phage therapy, antibiotic resistance and biosecurity.
Moderna’s First mRNA Flu Vaccine Approved by FDA: 26.6% More Effective Than Traditonal Flu Shots
The U.S. Food and Drug Administration (FDA) has approved Moderna’s first mRNA flu vaccine, mFlusiva, marking the first approval of
Oxford Launches World’s First Human Trial of Bundibugyo Ebola Vaccine
The University of Oxford has launched the world’s first Phase I clinical trial of a vaccine specifically designed to protect
Scientists Rethink Alzheimer’s Disease Trigger as New Research Challenges Traditional Theory
New research reveals that Alzheimer’s disease may trigger inside brain cells far earlier than previously thought. Discover how amyloid beta disrupts vital tau proteins, causing a catastrophic breakdown in the neuron’s transport system long before widespread plaques and tangles form.